Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and In Vitro Characterization

Table 5

Observed responses and prediction errors for model validation.

Dependent variables (responses)
Size (nm) ()		PDI ()		Log EE% (log )		Zeta potential (mV)	LE (%)
Observed ()	Error%	Observed; ()	Error%	Observed; ()	Error%	Observed; ()	Observed; ()
	-8.2%		-3.51	()	-0.54